LeonaBio (LONA) EBITDA (2019 - 2026)
LeonaBio (LONA) reported EBITDA of -$33.0 million for Q1 2026, down 260.26% year-over-year from $20.6 million in Q1 2025, and up 60.24% on a QoQ basis from -$82.9 million in Q4 2025.
LeonaBio (LONA) has 8 years of EBITDA data on file, last reported at -$33.0 million in Q1 2026.
- Quarterly EBITDA fell 260.26% year-over-year to -$33.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$129.4 million (down 62.57% YoY) and the FY2025 annual result came in at -$105.6 million, down 9.34% from the prior year.
- EBITDA rose to -$33.0 million in Q1 2026 per LONA's latest filing, from -$82.9 million in the prior quarter.
- Across five years, EBITDA topped out at -$6.6 million in Q3 2025 and bottomed at -$82.9 million in Q4 2025.
- The 5-year median for EBITDA is -$26.8 million (2024), against an average of -$26.4 million.
- Peak annual rise in EBITDA reached 76.97% in 2025, while the deepest fall reached 452.42% in 2025.
- Tracing LONA's EBITDA over 5 years: stood at -$29.6 million in 2022, then advanced by 8.99% to -$27.0 million in 2023, then surged by 44.34% to -$15.0 million in 2024, then tumbled by 452.42% to -$82.9 million in 2025, then surged by 60.24% to -$33.0 million in 2026.
- Per Business Quant, the three latest LONA EBITDA figures stand at -$33.0 million (Q1 2026), -$82.9 million (Q4 2025), and -$6.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -13.63 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -19.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -14.44 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.14 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -3.82 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 661.60 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 201.19 Mn |
| 10 | LeonaBio | 181.52 Mn | 113.84 Mn | - | -32.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.96 Mn |
| Dec 31, 2025 | -82.89 Mn |
| Sep 30, 2025 | -6.61 Mn |
| Jun 30, 2025 | -6.97 Mn |
| Mar 31, 2025 | -9.15 Mn |
| Dec 31, 2024 | -15.01 Mn |
| Sep 30, 2024 | -28.70 Mn |
| Jun 30, 2024 | -26.76 Mn |
| Mar 31, 2024 | -26.13 Mn |
| Dec 31, 2023 | -26.96 Mn |
| Sep 30, 2023 | -32.71 Mn |
| Jun 30, 2023 | -29.51 Mn |
| Mar 31, 2023 | -26.89 Mn |
| Dec 31, 2022 | -29.62 Mn |
| Sep 30, 2022 | -20.74 Mn |
| Jun 30, 2022 | -24.80 Mn |
| Mar 31, 2022 | -22.05 Mn |
| Dec 31, 2021 | -16.73 Mn |
| Sep 30, 2021 | -15.71 Mn |
| Jun 30, 2021 | -13.97 Mn |
| Mar 31, 2021 | -8.87 Mn |
| Dec 31, 2020 | -7.68 Mn |
| Sep 30, 2020 | -8.45 Mn |
| Jun 30, 2020 | -1.99 Mn |
| Mar 31, 2020 | -1.81 Mn |
| Dec 31, 2019 | -974,000.00 |
| Sep 30, 2019 | -1.53 Mn |